Your browser doesn't support javascript.
loading
Alternatives of mesenchymal stem cell-derived exosomes as potential therapeutic platforms.
Lee, Sihun; Jung, Se Young; Yoo, Donghyeon; Go, Dabin; Park, Ji Yeong; Lee, Jong Min; Um, Wooram.
Afiliación
  • Lee S; Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.
  • Jung SY; Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.
  • Yoo D; Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.
  • Go D; Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.
  • Park JY; Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.
  • Lee JM; Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.
  • Um W; Department of Biotechnology, College of Fisheries Science, Pukyong National University, Busan, Republic of Korea.
Front Bioeng Biotechnol ; 12: 1478517, 2024.
Article en En | MEDLINE | ID: mdl-39315312
ABSTRACT
With outstanding therapeutic potential in the tissue regeneration and anti-inflammation, mesenchymal stem cell-derived exosomes (MSC-EXOs) have emerged as a prominent therapeutic in recent. However, poor production yield and reproducibility have remained as significant challenges of their practical applications. To surmount these challenges, various alternative materials with stem cell-like functions, have been recently investigated, however, there has been no comprehensive analysis in these alternatives so far. Here, we discuss the recent progress of alternatives of MSC-EXOs, including exosomes and exosome-like nanovesicles from various biological sources such as plants, milk, microbes, and body fluids. Moreover, we extensively compare each alternative by summarizing their unique functions and mode of actions to suggest the expected therapeutic target and future directions for developing alternatives for MSC-EXOs.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2024 Tipo del documento: Article